Basel K Al-Ramadi Selected Research

Paraoxon (E600)

1/2019	Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes.
1/2018	Cholinergic Activation Enhances Resistance to Oral Salmonella Infection by Modulating Innate Immune Defense Mechanisms at the Intestinal Barrier.
1/2016	Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Basel K Al-Ramadi Research Topics

Disease

9	Neoplasms (Cancer) 06/2021 - 09/2008
8	Infections 01/2021 - 01/2005
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2016
3	Salmonella Infections (Salmonellosis) 01/2018 - 06/2012
2	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2019 - 11/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 12/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2016
2	Hyperglycemia 01/2019 - 01/2016
1	Stroke (Strokes) 01/2021
1	Pulmonary Arterial Hypertension 01/2020
1	Adenocarcinoma 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Leukemia 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Lung Neoplasms (Lung Cancer) 09/2019
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Systemic Scleroderma (Systemic Sclerosis) 12/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Neutropenia 11/2018
1	Persistent Infection 01/2018
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Osteomyelitis 10/2017
1	Inflammation (Inflammations) 10/2016
1	Anemia 01/2016
1	Experimental Melanoma 09/2008
1	Splenomegaly 04/2003

Drug/Important Bio-Agent (IBA)

3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 01/2016
3	Paraoxon (E600)IBA 01/2019 - 01/2016
3	CytokinesIBA 06/2012 - 01/2005
2	FlavonoidsIBA 04/2021 - 09/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2019
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2019 - 01/2018
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 01/2016
2	CD40 Ligand (CD40L)IBA 01/2019 - 11/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2016
2	AutoantibodiesIBA 12/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 05/2016 - 02/2013
1	AntioxidantsIBA 04/2021
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 01/2021
1	ambrisentan FDA Link 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2020
1	Endothelins (Endothelin)IBA 01/2020
1	src-Family KinasesIBA 09/2019
1	Tyrosine (L-Tyrosine)FDA Link 09/2019
1	Growth Factor ReceptorsIBA 09/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Cholinergic ReceptorsIBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	MecamylamineIBA 01/2019
1	Immunoglobulin G (IgG)IBA 12/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Estrogen ReceptorsIBA 01/2017
1	SilverIBA 10/2016
1	Pharmaceutical PreparationsIBA 05/2016
1	Transferrin (beta 2 Transferrin)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Interleukin-4 (Interleukin 4)IBA 06/2014
1	Interleukin-12 (IL 12)IBA 06/2012
1	Acetates (Acetic Acid Esters)FDA Link 04/2003

Therapy/Procedure

8	Therapeutics 06/2021 - 09/2008
4	Immunotherapy 01/2021 - 09/2008
2	Drug Therapy (Chemotherapy) 01/2018 - 05/2016
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Radiotherapy 01/2018
1	Neoadjuvant Therapy 05/2016